Literature DB >> 8117193

Treatment of trigeminal neuralgia by posterior fossa microvascular decompression.

K Cutbush1, R L Atkinson.   

Abstract

A series of 109 cases of microvascular decompression for intractable trigeminal neuralgia was reviewed. Operations were performed by a single surgeon and cases were reviewed independently by the one author. The failure rate in this study was 17.6%. A further 6.5% of cases endured brief recurrences not requiring treatment. Two-thirds of significant recurrences occurred within the initial 12 months. Long-term complications were experienced in 7.4% of cases. There was one postoperative mortality occurring in a patient with a large fibroblastic meningioma invading the brain stem. The classic Jannetta approach was modified following the first 32 cases allowing the cerebellum to be depressed inferiorly with a subsequent decline in the rate of loss of hearing from 12.5 to 3.7%. In over 70% of cases an aberrant superior cerebellar artery was found compressing the fifth cranial nerve. Patients had dental work performed in an attempt to control the pain prior to operation in 44% of cases.

Entities:  

Mesh:

Year:  1994        PMID: 8117193     DOI: 10.1111/j.1445-2197.1994.tb02171.x

Source DB:  PubMed          Journal:  Aust N Z J Surg        ISSN: 0004-8682


  3 in total

1.  Adverse Events After Microvascular Decompression: A National Surgical Quality Improvement Program Analysis.

Authors:  David J Cote; Hormuzdiyar H Dasenbrock; William B Gormley; Timothy R Smith; Ian F Dunn
Journal:  World Neurosurg       Date:  2019-05-11       Impact factor: 2.104

2.  Vascular Decompression of Trigeminal and Facial Nerves in the Posterior Fossa under Endoscope-Assisted Keyhole Conditions.

Authors:  P Charalampaki; A M Kafadar; P Grunert; A Ayyad; A Perneczky
Journal:  Skull Base       Date:  2008-03

Review 3.  Hearing Loss following Posterior Fossa Microvascular Decompression: A Systematic Review.

Authors:  Matthew Bartindale; Matthew Kircher; William Adams; Neelam Balasubramanian; Jeffrey Liles; Jason Bell; John Leonetti
Journal:  Otolaryngol Head Neck Surg       Date:  2017-09-12       Impact factor: 3.497

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.